Ad www.ProStocks.com
FREE Account Opening + No Clearing Fees + Rs 999 API Access
|
|
| Issue Open | Feb 5, 2007 |
| Issue Close | Feb 8, 2007 |
| IPO Price | ₹380 |
| Face Value | ₹10 |
| IPO Size | ₹97.93 Cr |
| Listing At | BSE, NSE |
| IPO Lot Size | 15 |
Tue, 11 Jan 2022 16:00:00 GMT
SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single ...
Thu, 30 Dec 2021 12:34:00 GMT
Our ‘Invest’ call in the IPO of Gland Pharma (up 160 per cent from price ... social media handles as well as through SMS/Whatsapp and QR code modes. We began featuring your thoughts / comments ...
Wed, 05 Jan 2022 05:10:00 GMT
Visit CATO-SMS.com for more information. Pharm-Olam Pharm-Olam is a global clinical research organization that delivers right-sized trial services to pharmaceutical, biotechnology, government ...
Thu, 13 Jan 2022 02:28:00 GMT
SINGAPORE (The Straits Times/Asia News Network): Pharmaceutical company Hyphens Pharma officially launched the first e-pharmacy in Singapore to be registered under the Health Sciences Authority ...
Tue, 04 Jan 2022 16:00:00 GMT
Jan 05, 2022 (Investor Brand Network via COMTEX) -- The German pharmaceutical firm that worked with Pfizer in 2020 to develop the first coronavirus vaccine is nowdeveloping a new vaccinethat ...
Fri, 07 Jan 2022 17:03:00 GMT
Biotech company Absci said Friday it has a deal with the drugmaker Merck to collaborate on new pharmaceutical research ... price in the months since its IPO. After debuting at $16 in July ...
Wed, 05 Jan 2022 05:02:00 GMT
InMed Pharmaceuticals (NASDAQ:INM), a leader in the development, manufacturing, and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO ...
Thu, 13 Jan 2022 03:32:00 GMT
LAGOS: Startups in Nigeria are helping fight counterfeit pharmaceutical drugs in Africa’s most populous nation, where the prevalence rate of fake drugs is higher than the global average 10% and ...
Tue, 11 Jan 2022 10:22:00 GMT
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system ...
Fri, 07 Jan 2022 05:59:00 GMT
India’s largest private lender HDFC Bank has revised charges for its Insta Alert services being given by the bank via its Email and SMS. The information is now being flashed on its website “From 1st ...
Thu, 13 Jan 2022 01:34:00 GMT
sending SMS or WhatsApp as to who among the party leaders they want to be declared as the chief ministerial candidate. "No, Arvind Kejriwal is not in this race, let me clarify I am not in it ...
IPO Allotment Status is now available for SMS Pharmaceuticals Limited IPO. Issue was closed on February 08, 2007.
SMS Pharmaceuticals Ltd. listing date & Info :
Listing On: Wednesday, February 28, 2007
BSE Script Code: 532815
NSE Symbol: SMSPHARMA
Listing in:
ISIN: INE812G01017
Issue Price: Rs. 380/- Per share (Face Value of Rs. 10/-)
IPO Allotment Status is now available for SMS Pharmaceuticals Limited IPO. Issue was closed on February 08, 2007.
SMS Pharmaceuticals Limited is leading manufacturers and exporters of Active Pharmacy Ingredients and pharmaceutical intermediates in India, commonly known as Bulk Drug Manufacturer. SMS Pharmaceuticals Limited is coming up with initial public offer of 2,977,000 Equity Shares of Rs. 10/- Each.
The float is being routed through a 100 per cent book-building with price band between Rs 360 and Rs 380 a share. The company intends to list its shares on both the BSE and NSE.
Issue Open: 05 February 2007
Issue Close: 08 February 2007
The SMS Pharmaceuticals IPO is proposed to open on Feb 5, 2007. The IPO application ends on Feb 8, 2007.
Retail investors can apply in the retail or non-institutional investor category from Feb 5, 2007 to Feb 8, 2007. The SMS Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The SMS Pharmaceuticals IPO will open for subscription on Feb 5, 2007. The public issue will close on Feb 8, 2007.
Useful Articles
